BACKGROUND:The outcomes from an antiretroviral treatment (ART) program within the public sector in Myanmar have not been reported. This study documents retention and the risk factors for attrition in a large ART public health program in Myanmar. METHODS:A retrospective analysis of a cohort of adult patients enrolled in the Integrated HIV Care (IHC) Program between June 2005 and October 2011 and followed up until April 2012 is presented. The primary outcome was attrition (death or loss-follow up); a total of 10,223 patients were included in the 5-year cumulative survival analysis. Overall 5,718 patients were analyzed for the risk factors for attrition using both logistic regression and flexible parametric survival models. RESULT:The mean age...
Factors associated with attrition after ART initiation after ART initiation among people living with...
Background: Patient retention in antiretroviral therapy (ART) programs remains a major challenge in ...
ART, anti-retroviral therapy; HIV, human immunodeficiency virus; PLHIV, people living with HIV; kg, ...
BackgroundThe outcomes from an antiretroviral treatment (ART) program within the public sector in My...
Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in ...
The outcomes from an antiretroviral treatment (ART) program within the public sector in Myanmar have...
Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in ...
Background: High retention rates have been documented among patients receiving antiretroviral therap...
BACKGROUND: Antiretroviral treatment (ART) coverage in Myanmar is well below average. This study des...
SETTING:Myanmar National AIDS Program has had significant scale-up of services and changes in CD4 el...
Background: In Myanmar, HIV seropositive children are being enrolled in an integrated HIV care (IHC)...
OBJECTIVES—We assessed retention and predictors of attrition (recorded death or loss to follow-up) i...
Among adults eligible for antiretroviral therapy (ART) in Thyolo (rural Malawi) and Kibera (Nairobi,...
Background: Myanmar has a high burden of Human Immunodeficiency Virus (HIV) and second-line antiretr...
Introduction: There is a growing interest in the potential contribution the private sector can make ...
Factors associated with attrition after ART initiation after ART initiation among people living with...
Background: Patient retention in antiretroviral therapy (ART) programs remains a major challenge in ...
ART, anti-retroviral therapy; HIV, human immunodeficiency virus; PLHIV, people living with HIV; kg, ...
BackgroundThe outcomes from an antiretroviral treatment (ART) program within the public sector in My...
Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in ...
The outcomes from an antiretroviral treatment (ART) program within the public sector in Myanmar have...
Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in ...
Background: High retention rates have been documented among patients receiving antiretroviral therap...
BACKGROUND: Antiretroviral treatment (ART) coverage in Myanmar is well below average. This study des...
SETTING:Myanmar National AIDS Program has had significant scale-up of services and changes in CD4 el...
Background: In Myanmar, HIV seropositive children are being enrolled in an integrated HIV care (IHC)...
OBJECTIVES—We assessed retention and predictors of attrition (recorded death or loss to follow-up) i...
Among adults eligible for antiretroviral therapy (ART) in Thyolo (rural Malawi) and Kibera (Nairobi,...
Background: Myanmar has a high burden of Human Immunodeficiency Virus (HIV) and second-line antiretr...
Introduction: There is a growing interest in the potential contribution the private sector can make ...
Factors associated with attrition after ART initiation after ART initiation among people living with...
Background: Patient retention in antiretroviral therapy (ART) programs remains a major challenge in ...
ART, anti-retroviral therapy; HIV, human immunodeficiency virus; PLHIV, people living with HIV; kg, ...